H1N1 Vaccines Market: Global Industry Analysis and Forecast to 2020
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Vaccines can be categorized into many types such as inactivated vaccines, attenuated vaccines, toxoid, and conjugate.
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Vaccines can be categorized into many types such as inactivated vaccines, attenuated vaccines, toxoid, and conjugate.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>H1N1</strong> <strong>Vaccines</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>to</strong> <strong>2020</strong><br />
Persistence <strong>Market</strong> Research<br />
<strong>H1N1</strong> <strong>Vaccines</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong><br />
<strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>to</strong> <strong>2020</strong><br />
Persistence <strong>Market</strong> Research 1
<strong>H1N1</strong> <strong>Vaccines</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>to</strong> <strong>2020</strong><br />
Persistence <strong>Market</strong> Research Released New <strong>Market</strong> Report on “<strong>H1N1</strong> <strong>Vaccines</strong> <strong>Market</strong>:<br />
<strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>to</strong> <strong>2020</strong>”.<br />
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing<br />
microorganism <strong>and</strong> is made from weakened or killed forms of the microbe, its <strong>to</strong>xins or one of its surface<br />
proteins. <strong>Vaccines</strong> can be categorized in<strong>to</strong> many types such as inactivated vaccines, attenuated vaccines,<br />
<strong>to</strong>xoid, <strong>and</strong> conjugate. Cholera, influenza, hepatitis A, polio, <strong>and</strong> rabies vaccines are inactivated vaccines.<br />
The global vaccines market is categorized on the basis of the different diseases that can either be<br />
prevented or treated with the help of vaccines. Various diseases that are treated using <strong>H1N1</strong> vaccines<br />
include influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella,<br />
etc. <strong>H1N1</strong> vaccines refer <strong>to</strong> the medical preparation specifically designed for the treatment of swine flu.<br />
<strong>H1N1</strong> influenza is an infectious disease. The causative agent of the same is a variant of the swine <strong>H1N1</strong><br />
virus. The <strong>H1N1</strong> virus is a RNA virus belonging <strong>to</strong> the orthomyxoviridae family <strong>and</strong> it infects the nose,<br />
lungs, <strong>and</strong> throat. In addition <strong>to</strong> humans, this virus may infect different other species such as birds, swine,<br />
horses, etc. On the basis of its surface composition, <strong>H1N1</strong> virus can be classified in<strong>to</strong> neuraminidase <strong>and</strong><br />
hemagglutinin. Hemagglutinin is used by the virus <strong>to</strong> bind itself <strong>to</strong> the recep<strong>to</strong>rs of the host cell in order <strong>to</strong><br />
facilitate its entry in<strong>to</strong> the host cell. The <strong>H1N1</strong> vaccines market is growing at a significant rate due <strong>to</strong> the<br />
increasing elderly population prone <strong>to</strong> such infectious diseases. In addition, rise in the prevalence of<br />
chronic diseases such as lung diseases, asthma, neurological disorders, etc. along with technological<br />
advancements in the field are driving the global market for <strong>H1N1</strong> vaccines.<br />
Buy Full Report: http://www.persistencemarketresearch.com/market-research/h1n1-vaccinesmarket.asp<br />
North America <strong>and</strong> Europe dominate the global <strong>H1N1</strong> vaccines market. This is due <strong>to</strong> improved research<br />
infrastructure in these regions. The U.S. represents the largest market for <strong>H1N1</strong> vaccines, followed by<br />
Canada, in North America. In Europe, France <strong>and</strong> Germany hold major shares of this market. However,<br />
the Asian <strong>H1N1</strong> vaccines market is expected <strong>to</strong> exhibit a high growth rate in the next five years due <strong>to</strong><br />
increasing awareness among people about preventable diseases. Several government associations have<br />
launched various programs <strong>to</strong> raise awareness among people about various infectious diseases in Asia.<br />
This has resulted in the significant rise in dem<strong>and</strong> for <strong>H1N1</strong> vaccines for the prevention of swine flu.<br />
Moreover, several companies are constructing their manufacturing <strong>and</strong> research facilities in developing<br />
regions given the low wages <strong>to</strong> be paid, availability of a large talent pool, <strong>and</strong> less stringent environment<br />
<strong>and</strong> health <strong>and</strong> safety regulations. Japan, China, <strong>and</strong> India are expected <strong>to</strong> be the fastest growing <strong>H1N1</strong><br />
vaccines markets in Asia.<br />
Persistence <strong>Market</strong> Research 2
<strong>H1N1</strong> <strong>Vaccines</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>to</strong> <strong>2020</strong><br />
In recent times, the increasing prevalence of swine flu <strong>and</strong> novel vaccine technologies are some of the<br />
major drivers for the global <strong>H1N1</strong> vaccines market. In addition, increased research in the field of vaccine<br />
technologies <strong>and</strong> substantial government support are driving this market. However, lack of awareness<br />
<strong>and</strong> absence of experienced medical professionals are restraining the growth of <strong>H1N1</strong> vaccines market.<br />
Furthermore, high capital requirement <strong>and</strong> stringent regulations are also hindering the growth of the<br />
global market for <strong>H1N1</strong> vaccines.<br />
Growing demographics <strong>and</strong> economies in developing countries such as India <strong>and</strong> China, the discovery of<br />
new products with greater focus on efficiency, <strong>and</strong> advancements in the field of biomedical science are<br />
expected <strong>to</strong> offer good opportunities <strong>to</strong> the players in the <strong>H1N1</strong> vaccines market. Frequent mergers <strong>and</strong><br />
collaborations between manufacturing companies <strong>and</strong> government associations as well as product<br />
launches are the current trends in the global <strong>H1N1</strong> vaccines market. Major players in this market are<br />
Medimmune, GlaxoSmithKline, Novartis, <strong>and</strong> Sanofi Pastuer. Others with a significant presence in the<br />
global <strong>H1N1</strong> vaccines market are Commonwealth Serum Labora<strong>to</strong>ries (CSL), Sinovac, <strong>and</strong> Baxter.<br />
Request Full TOC: http://www.persistencemarketresearch.com/<strong>to</strong>c/3779<br />
Key points covered in the report:-<br />
1. Report segments the market on the basis of types, application, products, technology, etc<br />
(as applicable)<br />
2. The report covers geographic segmentation<br />
North America<br />
Europe<br />
Asia<br />
RoW<br />
3. The report provides the market size <strong>and</strong> forecast for the different segments <strong>and</strong><br />
geographies for the period of 2010 <strong>to</strong> <strong>2020</strong><br />
4. The report provides company profiles of some of the leading companies operating in the<br />
market<br />
5. The report also provides porters five forces analysis of the market.<br />
Browse the full “All Upcoming Persistence <strong>Market</strong>'s ” report at<br />
http://www.persistencemarketresearch.com/forthcoming-reports.asp<br />
About Us:<br />
Persistence <strong>Market</strong> Research is a global market research firm specializing- syndicated<br />
research, cus<strong>to</strong>m research, <strong>and</strong> consulting services<br />
Persistence <strong>Market</strong> Research 3
<strong>H1N1</strong> <strong>Vaccines</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>to</strong> <strong>2020</strong><br />
At Persistence <strong>Market</strong> Research (PMR), we are in the business of accelerating your business.<br />
As a full-service market research firm, we st<strong>and</strong> committed <strong>to</strong> bringing more accuracy <strong>and</strong><br />
speed <strong>to</strong> your business decisions. From ready-<strong>to</strong>-purchase market research reports <strong>to</strong><br />
cus<strong>to</strong>mized global research solutions, our engagement models are highly flexible without<br />
compromising on our deep-seated research values. Briefly stated, our mission is <strong>to</strong> give you<br />
access <strong>to</strong> forecasts <strong>and</strong> trends analyses that put you on the path <strong>to</strong> profitability.<br />
PMR’s Services Go Beyond Gleaning Data:<br />
Most enterprises believe that IT <strong>and</strong> databases are enough <strong>to</strong> make an accurate decision. While<br />
we do not dispute that, consider this: How long does it take <strong>to</strong> make an accurate <strong>and</strong> strategic<br />
million-dollar decision? We strive <strong>to</strong> deliver both even with dem<strong>and</strong>ing deadlines.<br />
Facilitating Rapid <strong>and</strong> Informed Business Decisions<br />
PMR was founded with one goal in mind: <strong>to</strong> offer enterprises a tangible business advantage by<br />
carefully balancing traditional <strong>and</strong> modern-day research methodologies.<br />
Contact Us:<br />
Addie Thomes<br />
305 Broadway,<br />
7th Floor,<br />
New York City, NY 10007,<br />
United States.<br />
Phone: +1-646-568-7751<br />
USA/Canada Toll Free Number.<br />
1-800-961-0353<br />
E-mail: Sales@persistencemarketresearch.com<br />
Web : http://www.persistencemarketresearch.com/<br />
Persistence <strong>Market</strong> Research 4
Change language